Mitsubishi UFJ Asset Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1M | Buy |
11,664
+1,703
| +17% | +$153K | ﹤0.01% | 804 |
|
|
2025
Q4 | $870K | Sell |
9,961
-707
| -7% | -$53.7K | ﹤0.01% | 832 |
|
|
2025
Q3 | $611K | Buy |
10,668
+32
| +0.3% | +$1.84K | ﹤0.01% | 853 |
|
|
2025
Q2 | $628K | Buy |
10,636
+2,196
| +26% | +$142K | ﹤0.01% | 839 |
|
|
2025
Q1 | $618K | Buy |
8,440
+355
| +4% | +$29.3K | ﹤0.01% | 829 |
|
|
2024
Q4 | $669K | Sell |
8,085
-1,992
| -20% | -$157K | ﹤0.01% | 842 |
|
|
2024
Q3 | $721K | Buy |
10,077
+184
| +2% | +$13K | ﹤0.01% | 828 |
|
|
2024
Q2 | $678K | Sell |
9,893
-1,581
| -14% | -$94.5K | ﹤0.01% | 816 |
|
|
2024
Q1 | $615K | Sell |
11,474
-535
| -4% | -$28.8K | ﹤0.01% | 850 |
|
|
2023
Q4 | $624K | Buy |
12,009
+1,825
| +18% | +$88.9K | ﹤0.01% | 862 |
|
|
2023
Q3 | $506K | Sell |
10,184
-318
| -3% | -$17.8K | ﹤0.01% | 892 |
|
|
2023
Q2 | $625K | Buy |
10,502
+1,904
| +22% | +$109K | ﹤0.01% | 881 |
|
|
2023
Q1 | $487K | Hold |
8,598
| – | – | ﹤0.01% | 904 |
|
|
2022
Q4 | $629K | Sell |
8,598
-282
| -3% | -$19.2K | ﹤0.01% | 874 |
|
|
2022
Q3 | $529K | Hold |
8,880
| – | – | ﹤0.01% | 882 |
|
|
2022
Q2 | $499K | Sell |
8,880
-1,441
| -14% | -$94.7K | ﹤0.01% | 908 |
|
|
2022
Q1 | $761K | Buy |
10,321
+21
| +0.2% | +$1.46K | ﹤0.01% | 876 |
|
|
2021
Q4 | $762K | Buy |
10,300
+1,870
| +22% | +$136K | ﹤0.01% | 884 |
|
|
2021
Q3 | $646K | Sell |
8,430
-272
| -3% | -$21.8K | ﹤0.01% | 897 |
|
|
2021
Q2 | $675K | Buy |
8,702
+105
| +1% | +$7.46K | ﹤0.01% | 914 |
|
|
2021
Q1 | $530K | Buy |
8,597
+3,334
| +63% | +$211K | ﹤0.01% | 880 |
|
|
2020
Q4 | $343K | Buy |
5,263
+662
| +14% | +$38.1K | ﹤0.01% | 877 |
|
|
2020
Q3 | $228K | Sell |
4,601
-1,551
| -25% | -$80K | ﹤0.01% | 883 |
|
|
2020
Q2 | $294K | Sell |
6,152
-518
| -8% | -$25K | ﹤0.01% | 843 |
|
|
2020
Q1 | $284K | Buy |
6,670
+1,447
| +28% | +$71.5K | ﹤0.01% | 808 |
|
|
2019
Q4 | $305K | Sell |
5,223
-372
| -7% | -$20.2K | ﹤0.01% | 825 |
|
|
2019
Q3 | $286K | Buy |
5,595
+307
| +6% | +$14.6K | ﹤0.01% | 794 |
|
|
2019
Q2 | $224K | Buy |
5,288
+1,203
| +29% | +$52.2K | ﹤0.01% | 824 |
|
|
2019
Q1 | $202K | Buy |
4,085
+471
| +13% | +$21.3K | ﹤0.01% | 802 |
|
|
2018
Q4 | $138K | Buy |
3,614
+567
| +19% | +$28.3K | ﹤0.01% | 798 |
|
|
2018
Q3 | $173K | Buy |
+3,047
| New | +$160K | ﹤0.01% | 788 |
|
Other funds holding GMED
VCM
VPM
SC
Mitsubishi UFJ Asset Management's GMED Position: Q1 2026 in Review
Mitsubishi UFJ Asset Management increased its Globus Medical (GMED) stake by 17% in Q1 2026, buying an estimated $153K and bringing the position to 11,664 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #804.
Mitsubishi UFJ Asset Management first reported a position in GMED in Q3 2018 and has held it in 31 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Mitsubishi UFJ Asset Management held 11,664 shares of Globus Medical worth $1M as of Q1 2026.
- Mitsubishi UFJ Asset Management bought 1,703 Globus Medical shares in Q1 2026, an estimated $153K.
- Globus Medical made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q1 2026, its #804 holding.
- Mitsubishi UFJ Asset Management first reported a position in Globus Medical in Q3 2018 and has held it in 31 quarters since.
- 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2026, filed 12 May 2026.